Clinical Trials Search | Clareo Health

About Pricing FAQs Blog

Loading clinical trials...

Clareo Health Find Clinical Trials →

Filters

Sort by

Status

Recruiting(Enrolling)

Not yet recruiting

Active, not recruiting

Enrolling by invitation(Enrolling)

Completed

Terminated

Phase

Early Phase 1

Phase 1

Phase 1/Phase 2

Phase 2

Phase 2/Phase 3

Phase 3

Phase 4

Not Applicable

Eligibility

Accepts healthy volunteers

Showing 1-1 of 1 trials

RECRUITINGPHASE2

ACTEMRA® for the Treatment of Pediatric Adamantinomatous Craniopharyngioma

NCT05233397

ACTEMRA (tocilizumab) is an IL-6 receptor antagonist used for the treatment of adult Rheumatoid Arthritis as well as Polyarticular (PJIA) and Systemic (SJIA) Juvenile Idiopathic Arthritis. In this Phase II, the drug will be used to treat pediatric patients diagnosed with recurrent Adamantinomatous Craniopharyngioma including patients who have undergone surgery and/or radiation therapy.

Adamantinomatous CraniopharyngiomaRecurrent Adamantinomatous Craniopharyngioma

Nationwide Children's Hospital38 participantsStarted Dec 2022

Aurora, Colorado, United States • Washington D.C., District of Columbia, United States • Miami, Florida, United States +9 more locations

Data from ClinicalTrials.govTerms